INBS Stock Analysis: Buy, Sell, or Hold?
INBS - Intelligent Bio Solutions Inc. Common Stock
$3.35
0.48 (16.55%)
▲
5d:
+1.67%
30d:
-25.0%
90d:
-22.21%
BUY
HIGH Confidence
Analysis Updated: Mar 31, 2026 12:00 AM ET
Earnings: May 12, 2026
Get Alerted When INBS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: INBS trading at deep discount. Market pricing in -17.7% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: INBS trading at deep discount. Market pricing in -17.7% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$8.39
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$5.21
35.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: INBS is currently trading at $3.35, which is considered oversold relative to its 30-day fair value range of $3.42 to $4.29. From a valuation perspective, the stock is trading at a discount (Forward PE: 9.6) compared to its historical average (17.1). Remarkably, the market is currently pricing in an annual earnings decline of 17.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, INBS is in a uptrend. Immediate support is located at $2.86, while resistance sits at $3.82. The stock is showing strong short-term momentum, up 16.6% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.00 (+258.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, INBS is in a uptrend. Immediate support is located at $2.86, while resistance sits at $3.82. The stock is showing strong short-term momentum, up 16.6% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.00 (+258.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$3.42 -
$4.29
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.3%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+16.6%)
- BULLISH: Trading 258.7% below Wall St target ($12.00)
Fair Price Analysis
30-Day Fair Range
$3.42 -
$4.29
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$2.86
Resistance Level
$3.82
Current Trend
Uptrend
Technical data as of
Mar 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.56
Wall Street Target
$12.00
(+258.7%)
Revenue Growth (YoY)
47.6%
Valuation Discount vs History
-17.7% cheaper
PE vs Historical
9.6 vs 17.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-17.7%
(market-implied from PE analysis)
1-Year Target
$3.01
(-10%)
2-Year Target
$2.71
(-19%)
3-Year Target
$2.44
(-27%)
3-Yr Target (if PE normalizes)
(PE: 10→17)
$4.36
(+30%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.6 to 17.1
Stabilization Target:
$5.98
(+78.9%)
PE Expansion Potential:
+78.9%
Share & Embed Analysis
Last updated: March 31, 2026 8:01 PM ET
Data refreshes hourly during market hours. Next update: 9:01 PM
Data refreshes hourly during market hours. Next update: 9:01 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INBS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 61 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 53 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 52 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 64 BUY |